Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases
Funds clinical testing research for rare neurodegenerative disorders and therapeutic development.
The FDA Rare Neurodegenerative Disease Grants Program was established by the ACT for ALS Act of 2021 and has been active since 2022. Administered by the FDA Office of Orphan Products Development, the program funds clinical trials of interventions intended to prevent, diagnose, mitigate, treat, or cure amyotrophic lateral sclerosis (ALS) and other rare neurodegenerative diseases in both adults and …
Clinical trials of interventions to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children, funded under the ACT for ALS Act of 2021.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
BudgetIndirect Costs in Grants: Rates, MTDC, and Examples
Understand indirect costs in grants, including direct vs indirect costs, negotiated rates, de minimis rates, MTDC, funder caps, and budget narrative implications.
More from FDA OOPD
All grants from this funder →Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
🇺🇸FDA OOPD · United States
Funds natural-history studies that improve preparedness for rare disease trial pathways.
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
🇺🇸FDA OOPD · United States
Funds clinical research for rare disease products by supporting trial design and study execution.
Pediatric Device Consortia Grants Program
🇺🇸FDA OOPD · United States
Funds nonprofit pediatric device consortia building infrastructure for regulatory and development progress.
Similar grants
Browse the directory →
Making America Healthy Again — Dementia Disparities (OMH) — Seed
🇺🇸HHS · United States
Supports community-based teams reducing dementia and brain-health disparities in underserved groups through social-determinant-focused strategies.
NIH IGNITE Program — R61/R33 Phased Neurotherapeutic Grants
🇺🇸NIH · United States
Supports early neurotherapeutic translation through milestone-based translational funding.
US-Ireland R&D Partnership
🇮🇪HRB (Health Research Board Ire · Ireland
Connects United States and United Kingdom researchers through joint biomedical innovation grants.
NEI SBIR Phase I — Feasibility
🇺🇸NEI · United States
Supports United States. small businesses testing vision concepts through feasibility-focused grants.
NEI STTR Phase I — Feasibility
🇺🇸NEI · United States
Funds small business and research-partner teams on feasibility vision tools for future commercialization.
NIH SBIR Phase I
🇺🇸NIH SEED · United States
Funds early stage United States biomedical teams through NIH seed support for feasibility work on prototype ready ideas.